Metraipolis › archive › dc_a8f1bdcd9aa9

Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction — Europe PMC PMID:42730173

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42730173
DOI
10.14740/wjon2800
License (as archived)
solo-consultazione
Archived
2026-10-07T15:35:59.591Z
SHA-256 of the archived text
4466b3e79e98bf2d16f2d2c107bcc0b7f14543641fc4ba6cf558d8e3697fff48
Stable URL of this page
https://metraipolis.com/documento/dc_a8f1bdcd9aa9

How to cite

Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction — Europe PMC PMID:42730173 — Europe PMC (en), https://europepmc.org/article/MED/42730173 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8f1bdcd9aa9 (Metraipolis archive dc_a8f1bdcd9aa9, sha256 4466b3e79e98bf2d16f2d2c107bcc0b7f14543641fc4ba6cf558d8e3697fff48)
BibTeX
@misc{dca8f1bdcd9aa9,
  title = {Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction — Europe PMC PMID:42730173},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42730173},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8f1bdcd9aa9; sha256 4466b3e79e98bf2d16f2d2c107bcc0b7f14543641fc4ba6cf558d8e3697fff48},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42730173. Agents can read the archived copy with the MCP tool read_document.